Genfit S.A. (GNFTY)
OTCMKTS · Delayed Price · Currency is USD
6.06
-0.04 (-0.72%)
At close: Jan 9, 2026
Genfit Market Cap
Genfit has a market cap or net worth of $307.56 million as of January 9, 2026. Its market cap has increased by 68.53% in one year.
Market Cap
307.56M
Enterprise Value
344.09M
Revenue
52.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
$6.06
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 192.64M to 307.56M, an increase of 59.66%. That is a compound annual growth rate of 2.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 307.56M | -0.08% |
| Dec 31, 2025 | 307.82M | 68.67% |
| Dec 31, 2024 | 182.50M | -6.18% |
| Dec 29, 2023 | 194.52M | -7.62% |
| Dec 30, 2022 | 210.57M | -13.73% |
| Dec 31, 2021 | 244.08M | 28.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 503.78M |
| Northwest Biotherapeutics | 445.03M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 365.15M |
| Silence Therapeutics | 273.96M |